A strong Dysregulated Myeloid Component in the Epigenetic Landscape of Systemic Sclerosis: An Integrated DNA Methylome and Transcriptome Analysis
Por:
Martínez-López J, Ortiz-Fernandez L, Estupiñán-Moreno E, Kerick M, Andrés-León E, Terron-Camero LC, Carnero-Montoro E, Barturen G, Beretta L, Almeida I, Alarcón-Riquelme ME, Ballestar E, Acosta-Herrera M and Martín J
Publicada:
1 abr 2025
Ahead of Print:
1 dic 2024
Resumen:
Objective. Nongenetic factors influence systemic sclerosis (SSc) pathogenesis, underscoring epigenetics as a relevant contributor to the disease. We aimed to unravel DNA methylation abnormalities associated with SSc through an epigenome-wide association study. Methods. We analyzed DNA methylation data from whole-blood samples in 179 patients with SSc and 241 unaffected individuals to identify differentially methylated positions (DMPs) with a false discovery rate (FDR) <0.05. These results were further integrated with RNA sequencing data from the same patients to assess their functional consequence. Additionally, we examined the impact of DNA methylation changes on transcription factors and analyzed the relationship between alterations of the methylation and gene expression profile and serum proteins levels. Results. This analysis yielded 525 DMPs enriched in immune-related pathways, with leukocyte cell-cell adhesion being the most significant (FDR = 4.91 x 10(-9)), prioritizing integrins as they were exposed by integrating methylome and transcriptome data. Furthermore, through this integrative approach, we observed an enrichment of neutrophil-related pathways, highlighting this myeloid cell type as a relevant contributor in SSc pathogenesis. In addition, we uncovered novel profibrotic and proinflammatory mechanisms involved in the disease. Finally, the altered epigenetic and transcriptomic signature revealed an increased activity of CCAAT/enhancer-binding protein transcription factor family in SSc, which is crucial in the myeloid lineage development. Conclusion. Our findings uncover the impaired epigenetic regulation of the disease and its impact on gene expression, identifying new molecules for potential clinical applications and improving our understanding of SSc pathogenesis.
Filiaciones:
Martínez-López J:
Institute of Parasitology and Biomedicine López-Neyra, Consejo Superior de Investigaciones Científicas and Hospital Clínico San Cecilio, Instituto de Investigación Biosanitaria de Granada, Granada, Spain
Ortiz-Fernandez L:
Institute of Parasitology and Biomedicine López-Neyra, Consejo Superior de Investigaciones Científicas, Granada, Spain
Estupiñán-Moreno E:
Josep Carreras Research Institute, Barcelona, Spain
Kerick M:
Institute of Parasitology and Biomedicine López-Neyra, Consejo Superior de Investigaciones Científicas, Granada, Spain
Andrés-León E:
Institute of Parasitology and Biomedicine López-Neyra, Consejo Superior de Investigaciones Científicas, Granada, Spain
Terron-Camero LC:
Institute of Parasitology and Biomedicine López-Neyra, Consejo Superior de Investigaciones Científicas, Granada, Spain
Carnero-Montoro E:
Centre for Genomics and Oncological Research, Pfizer, University of Granada/Andalusian Regional Government, Granada, Spain
Barturen G:
Centre for Genomics and Oncological Research, Pfizer, University of Granada/Andalusian Regional Government, Granada, Spain
Beretta L:
Scleroderma Unit, Referral Center for Systemic Autoimmune Diseases, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy
Almeida I:
Centro Hospitalar Universitário do Porto and Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal
Alarcón-Riquelme ME:
Centre for Genomics and Oncological Research, Pfizer, University of Granada/Andalusian Regional Government, Granada, Spain
:
Josep Carreras Research Institute, Barcelona, Spain, and Health Science Center, East China Normal University, Shanghai, China
Acosta-Herrera M:
Institute of Parasitology and Biomedicine López-Neyra, Consejo Superior de Investigaciones Científicas and Hospital Clínico San Cecilio, Instituto de Investigación Biosanitaria de Granada, Granada, Spain
Martín J:
Institute of Parasitology and Biomedicine López-Neyra, Consejo Superior de Investigaciones Científicas, Granada, Spain
Green Submitted, hybrid
|